Permission to operate financial portfolio management by the German Federal Banking Supervisory Office (BaKred, now BaFin)
Takeover of the first fund mandate
Initiation and launch of MEDICAL BioHealth, start of partnership with Oppenheim Asset Management in Luxembourg.
Harald Schwarz and Jürgen Harter join Medical Strategy
MEDICAL BioHealth receives AA rating from Standard & Poor's for the first time
Dr. Michael Fischer receives three gold medals for the first time from Sauren Fonds Research
First award of the Long-Term Fund Management Rating (5 year) by Standard & Poor's for MEDICAL BioHealth
10th anniversary of MEDICAL BioHealth
Investment Advisory (as of 01.09.17 Fund Management) of RIM GLOBAL BIOSCIENCE.
Mario Linimeier is appointed Managing Director
Medical Strategy is awarded the FinanzResearch AWARD. In the field of independent asset managers in Germany, the company was rated "Outstanding".
At the "Funds Europe Awards" in London, Medical Strategy is awarded a special recommendation in the category "European Specialized Investment Company of the Year".
Medical Strategy receives seven Euro Fund Awards for MEDICAL BioHealth and RIM Global Bioscience
Katrin Winterstein appointed authorized signatory